STTK Q3 2020 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$284M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+36.5% YoY

Gross Profit

-$9M-384.8% margin

Operating Income

-$12M-486.2% margin

Net Income

-$12M-485.8% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-23.5%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$312,000

Balance Sheet

Total Assets

$145M

Total Liabilities

$203M

Stockholders' Equity

-$58M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+36.5%
Gross Profit	-$9M	-$6M	-52.1%
Operating Income	-$12M	-$8M	-57.3%
Net Income	-$12M	-$7M	-62.5%